Inventor · disambiguated record
Ian Livey
Also filed as: LIVEY IAN
11 granted patents·129 citations·filing 1992–2018
91Inventor score
Top patents by PatentIndex Score
11 records- 0189US11305000B2Chimeric OspA genes, proteins and methods of use thereofTHE RESEARCH FOUNDATION OF THE STATE UNIV OF NEW YORK·Filed 2018·Granted Apr 19, 2022·11 cites·24 claims
- 0281US9895434B2Chimeric OspA genes, proteins and methods of use thereofBAXALTA INC·Filed 2016·Granted Feb 20, 2018·2 cites·12 claims
- 0381US9023367B2Compositions comprising chimeric OSPA molecules and methods of use thereofBAXTER INT·Filed 2013·Granted May 5, 2015·11 cites·24 claims
- 0479US5530103AMethod for the purification of PC protein from Borrelia burgdorferiIMMUNO AG·Filed 1993·Granted Jun 25, 1996·40 cites·1 claims
- 0578US9303073B2Chimeric OspA proteins and methods of use thereofBAXALTA INC·Filed 2013·Granted Apr 5, 2016·2 cites·17 claims
- 0678US8623376B2Chimeric OspA genes, proteins, and methods of use thereofCROWE BRIAN A·Filed 2011·Granted Jan 7, 2014·3 cites·17 claims
- 0778US8623375B2Chimeric OspA genes, proteins, and methods of use thereofCROWE BRIAN A·Filed 2011·Granted Jan 7, 2014·3 cites·35 claims
- 0877US9334311B2Chimeric OspA genes, proteins and methods of use thereofBAXALTA INC·Filed 2013·Granted May 10, 2016·2 cites·20 claims
- 0965US6221363B1Vaccine for the prevention of lyme diseaseBAXTER AG·Filed 1992·Granted Apr 24, 2001·15 cites·18 claims
- 1064US6486130B1Immunogenic formulation of OSPC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigensBAXTER VACCINE AG·Filed 1996·Granted Nov 26, 2002·23 cites·18 claims
- 1155US6872550B1Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigensBAXTER VACCINE AG·Filed 1994·Granted Mar 29, 2005·17 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Ian Livey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →